Close
4

Evonik Evonik

X

Company profile for OncXerna Therapeutics

  • Webinars & Exhibitions

PharmaCompass
About the Company
Related CompaniesRelated Companies
Existing precision medicines target just 10 percent of cancers – those with gene mutations or oncogenic drivers for a small number of genes. OncXerna Therapeutics is ushering in a new era of precision medicine, leveraging the company’s deep understanding of tumor biology at the RNA level to deliver more effective therapies for many more patients. OncXerna applies its understanding of RNA signatures to describe the dominant...
Existing precision medicines target just 10 percent of cancers – those with gene mutations or oncogenic drivers for a small number of genes. OncXerna Therapeutics is ushering in a new era of precision medicine, leveraging the company’s deep understanding of tumor biology at the RNA level to deliver more effective therapies for many more patients. OncXerna applies its understanding of RNA signatures to describe the dominant biology of the patient’s cancer and match it to therapies with mechanisms that modify the dominant biology to dramatically improve patient outcomes.

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Send me more info on How To Grow My Bussiness Digitally?
OncXerna Therapeutics
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
300 Fifth Avenue Suite 6040 Waltham, MA 02451
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY